Table 5 Complications in Routine F/U and Home F/U patients according to randomization group
From: Attrition in longitudinal randomized controlled trials: home visits make a difference
ROUTINE F/U, N=187 | HOME F/U, N=61 | |||||
|---|---|---|---|---|---|---|
EVENT | All % (n) | Low MAP N=97, % (n) | High MAP N=90 % (n) | All % (n) | Low MAP N=27, % (n) | High MAP N=34, % (n) |
Perioperative cardiac and neurologic morbidity and mortality | 6.4 (12) | 9.3 (9) | 3.3 (3) | 8.2 (5) | 14.8 (4) | 2.9 (1) |
6-month cardiac and neurologic morbidity and mortality | 2.7 (5) | 3.1 (3) | 2.2 (2) | 4.9 (3) | 3.7 (1) | 5.9 (2) |
Total cardiac and neurologic morbidity and mortality | 8.6 (16) | 12.4 (12) | 4.4 (4) | 9.8 (6) | 14.8 (4) | 5.9 (2) |
Functional decline (6 months) | 7.5 (12) | 9.4 (8) | 5.3 (4) | 7.0 (4) | 4.2 (1) | 9.1 (3) |
Neurocognitive dysfunction (6 months) | 12.7 (21) | 11.6 (10) | 13.8 (11) | 10.2 (6) | 14.8 (4) | 6.3 (2) |
Total Combined Outcome | 24.0 (45) | 28.9 (28) | 18.9 (17) | 14.8 (9) | 22.2 (6) | 8.8 (3) |